My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

scPharmaceuticals Inc. - Common Stock (NQ:SCPH)

5.670 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about scPharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 Next >

SCPH Stock Earnings: scPharmaceuticals Beats EPS, Beats Revenue for Q1 2024 ↗

May 14, 2024

SCPH stock results show that scPharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 05, 2024

Via Benzinga

Recap: scPharmaceuticals Q4 Earnings ↗

March 13, 2024

Via Benzinga

A Preview Of scPharmaceuticals's Earnings ↗

March 12, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 22, 2024

Via Benzinga

Recap: scPharmaceuticals Q3 Earnings ↗

November 08, 2023

Via Benzinga

Earnings Preview: scPharmaceuticals ↗

November 07, 2023

Via Benzinga

Earnings Outlook For scPharmaceuticals ↗

August 09, 2023

Via Benzinga

The Latest Analyst Ratings for scPharmaceuticals ↗

July 19, 2023

Via Benzinga

Analyst Ratings for scPharmaceuticals ↗

June 08, 2023

Via Benzinga

Earnings Scheduled For March 13, 2024 ↗

March 13, 2024

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.

Via Benzinga

Dow Up 150 Points; Gold Jumps Over 2% ↗

March 23, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 150 points on Thursday. The Dow traded up 0.47% to 32,180.26 while the NASDAQ rose 1.29% to 11,820.77. The S&P...

Via Benzinga

Earnings Preview For scPharmaceuticals ↗

March 21, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About scPharmaceuticals ↗

January 27, 2023

Via Benzinga

Expert Ratings for scPharmaceuticals ↗

December 01, 2022

Via Benzinga

5 Analysts Have This to Say About scPharmaceuticals ↗

December 01, 2022

Via Benzinga

Analyst Ratings for scPharmaceuticals ↗

November 10, 2022

Within the last quarter, scPharmaceuticals (NASDAQ:SCPH) has observed the following analyst ratings:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023 ↗

September 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 23, 2023

Via Benzinga

Earnings Scheduled For August 10, 2023 ↗

August 10, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.

Via Benzinga

Earnings Outlook For scPharmaceuticals ↗

May 09, 2023

Via Benzinga

Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 23, 2023

Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.

Via Benzinga

Nasdaq Surges Over 2%; Accenture To Reduce 19,000 Jobs ↗

March 23, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 450 points on Thursday. The Dow traded up 1.42% to 32,484.03 while the NASDAQ rose 2.40% to 11,949.60. The S&P 500,...

Via Benzinga

KB Home, Accenture, Netflix And Other Big Stocks Moving Higher On Thursday ↗

March 23, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 17, 2023

Via Benzinga

$5 Million Bet On Lifecore Biomedical? Check Out These 4 Stocks Insiders Are Buying ↗

November 30, 2022

Although US stocks closed mostly lower on Tuesday, there were a few notable insider trades.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022 ↗

December 01, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 22, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 21, 2022

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.